OBJECTIVE: To define the impact of chronic viremia and associated immune activation on B-cell exhaustion in HIV infection. DESIGN: Progressive HIV infection is marked by B-cell anergy and exhaustion coupled with dramatic hypergammaglobulinemia. Although both upregulation of CD95 and loss of CD21 have been used as markers of infection-associated B-cell dysfunction, little is known regarding the specific profiles of dysfunctional B cells and whether persistent viral replication and its associated immune activation play a central role in driving B-cell dysfunction. METHODS: Multiparameter flow cytometry was used to define the profile of dysfunctional B cells. The changes in the expression of CD21 and CD95 were tracked on B-cell subpopulations in patients with differential control of viral replication. RESULTS: : Although the emergence of exhausted, CD21 tissue-like memory B cells followed similar patterns in both progressors and controllers, the frequency of CD21 activated memory B cells was lower in spontaneous controllers. CONCLUSION: Our results suggest that the loss of CD21 and the upregulation of CD95 occur as separate events during the development of B-cell dysfunction. The loss of CD21 is a marker of B-cell exhaustion induced in the absence of appreciable viral replication, whereas the upregulation of CD95 is tightly linked to persistent viral replication and its associated immune activation. Thus, these dysfunctional profiles potentially represent two functionally distinct states within the B-cell compartment.
OBJECTIVE: To define the impact of chronic viremia and associated immune activation on B-cell exhaustion in HIV infection. DESIGN: Progressive HIV infection is marked by B-cell anergy and exhaustion coupled with dramatic hypergammaglobulinemia. Although both upregulation of CD95 and loss of CD21 have been used as markers of infection-associated B-cell dysfunction, little is known regarding the specific profiles of dysfunctional B cells and whether persistent viral replication and its associated immune activation play a central role in driving B-cell dysfunction. METHODS: Multiparameter flow cytometry was used to define the profile of dysfunctional B cells. The changes in the expression of CD21 and CD95 were tracked on B-cell subpopulations in patients with differential control of viral replication. RESULTS: : Although the emergence of exhausted, CD21 tissue-like memory B cells followed similar patterns in both progressors and controllers, the frequency of CD21 activated memory B cells was lower in spontaneous controllers. CONCLUSION: Our results suggest that the loss of CD21 and the upregulation of CD95 occur as separate events during the development of B-cell dysfunction. The loss of CD21 is a marker of B-cell exhaustion induced in the absence of appreciable viral replication, whereas the upregulation of CD95 is tightly linked to persistent viral replication and its associated immune activation. Thus, these dysfunctional profiles potentially represent two functionally distinct states within the B-cell compartment.
Authors: Angela Malaspina; Susan Moir; Susan M Orsega; Joshua Vasquez; Natalie J Miller; Eileen T Donoghue; Shyamasundaran Kottilil; Misrak Gezmu; Dean Follmann; Galina M Vodeiko; Roland A Levandowski; JoAnn M Mican; Anthony S Fauci Journal: J Infect Dis Date: 2005-03-24 Impact factor: 5.226
Authors: Susan Moir; Angela Malaspina; Oxana K Pickeral; Eileen T Donoghue; Joshua Vasquez; Natalie J Miller; Surekha R Krishnan; Marie A Planta; John F Turney; J Shawn Justement; Shyamasundaran Kottilil; Mark Dybul; JoAnn M Mican; Colin Kovacs; Tae-Wook Chun; Charles E Birse; Anthony S Fauci Journal: J Exp Med Date: 2004-09-06 Impact factor: 14.307
Authors: Silvia Portugal; Nyamekye Obeng-Adjei; Susan Moir; Peter D Crompton; Susan K Pierce Journal: Cell Immunol Date: 2017-07-11 Impact factor: 4.868
Authors: Margaret E Ackerman; Max Crispin; Xiaojie Yu; Kavitha Baruah; Austin W Boesch; David J Harvey; Anne-Sophie Dugast; Erin L Heizen; Altan Ercan; Ickwon Choi; Hendrik Streeck; Peter A Nigrovic; Chris Bailey-Kellogg; Chris Scanlan; Galit Alter Journal: J Clin Invest Date: 2013-04-08 Impact factor: 14.808
Authors: Tullia C Bruno; Peggy J Ebner; Brandon L Moore; Olivia G Squalls; Katherine A Waugh; Evgeniy B Eruslanov; Sunil Singhal; John D Mitchell; Wilbur A Franklin; Daniel T Merrick; Martin D McCarter; Brent E Palmer; Jeffrey A Kern; Jill E Slansky Journal: Cancer Immunol Res Date: 2017-08-28 Impact factor: 11.151
Authors: Ramla F Tanko; Rubina Bunjun; Smritee Dabee; Shameem Z Jaumdally; Maricianah Onono; Gonasagrie Nair; Thesla Palanee-Phillips; Rushil Harryparsad; Anna Ursula Happel; Hoyam Gamieldien; Yamkela Qumbelo; Musalula Sinkala; Caitlin W Scoville; Kate Heller; Jared M Baeten; Steven E Bosinger; Adam Burgener; Renee Heffron; Heather B Jaspan; Jo Ann S Passmore Journal: J Infect Dis Date: 2022-09-13 Impact factor: 7.759